Target (CBDY) Intangibles (2014 - 2019)
Target (CBDY) reported Intangibles of $2.2 million for Q3 2019, up 1630.22% quarter-over-quarter from $127546.0 in Q3 2017.
Target (CBDY) Intangibles (2014 - 2019) Analysis & Trends
Target (CBDY) has 4 years of Intangibles data on file, last reported at $2.2 million in Q3 2019.
- Intangibles for Q3 2019 came in at $2.2 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2019 was $2.2 million (changed N/A YoY), and the FY2016 annual result was $137611.0, changed N/A from the prior year.
- Intangibles improved to $2.2 million in Q3 2019 per CBDY's latest filing, from $127546.0 in the prior quarter.
- Over five years, Intangibles peaked at $2.2 million in Q3 2019 and troughed at $127546.0 in Q3 2017.
- A 3-year average of $547393.6 and a median of $134171.0 in 2017 frame the typical range for Intangibles.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.61 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 959.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.57 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.23 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.80 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 261.03 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 936.46 Mn |
| 10 | Target | - | - | 191,787.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 2.21 Mn |
| Sep 30, 2017 | 127,546.00 |
| Jun 30, 2017 | 130,817.00 |
| Mar 31, 2017 | 134,171.00 |
| Dec 31, 2016 | 137,611.00 |
| Sep 30, 2014 | 70,000.00 |